Sight Sciences CLO sells shares to cover RSU taxes

Sight Sciences, Inc. Chief Legal Officer Jeremy B. Hayden sold 13,761 shares of common stock on April 6, 2026 at a weighted average price of $3.55 per share.

Rhea-AI Filing Summary

Sight Sciences, Inc. Chief Legal Officer Jeremy B. Hayden sold 13,761 shares of common stock on April 6, 2026 at a weighted average price of $3.55 per share. The shares were sold to cover his tax liability arising from the vesting of restricted stock units.

After this tax-related sale, he held a total of 369,770 shares, including 87,274 shares of common stock and 282,496 additional shares that will be received upon future vesting and settlement of RSUs.

Insider Trade Summary 10b5-1

Net Seller: 13,761 shares

Net Sell 1 txn

Insider HAYDEN JEREMY B.

Role Chief Legal Officer

Sold 13,761 shs ($49K)

Type	Security	Shares	Price	Value
Sale	Common Stock	13,761	$3.55	$49K

Holdings After Transaction: Common Stock — 369,770 shares (Direct)

Footnotes (3)

1. F1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. F2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Includes (i) 87,274 shares of Common Stock, and (ii) 282,496 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

Key Figures

Shares sold: 13,761 shares Weighted average sale price: $3.55 per share Shares held after transaction: 369,770 shares +2 more

5 metrics

Shares sold 13,761 shares Common stock sold on April 6, 2026

Weighted average sale price $3.55 per share Open-market sale price range $3.43–$3.58

Shares held after transaction 369,770 shares Total common stock position following the sale

Currently held common stock 87,274 shares Portion of post-transaction holdings in common stock

Unvested RSU-linked shares 282,496 shares Shares to be acquired upon future RSU vesting and settlement

Key Terms

restricted stock units, weighted average price, tax liability

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

tax liability financial

"sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SGHT’s Chief Legal Officer report?

Sight Sciences’ Chief Legal Officer Jeremy B. Hayden reported selling 13,761 shares of common stock. The transaction occurred on April 6, 2026 and was executed as an open-market sale according to the Form 4 disclosure.

Why did Jeremy B. Hayden sell Sight Sciences (SGHT) shares?

The shares were sold to cover Jeremy B. Hayden’s tax liability from vesting restricted stock units. This means the sale was linked to equity compensation taxation rather than a discretionary reduction of his overall economic exposure to Sight Sciences.

At what price were the SGHT shares sold by the Chief Legal Officer?

The shares were sold at a weighted average price of $3.55 per share. Trades occurred in multiple transactions within a price range from $3.43 to $3.58, as described in the Form 4 footnotes.

How many Sight Sciences shares does Jeremy B. Hayden hold after the sale?

After the sale, Jeremy B. Hayden held 369,770 shares in total. This includes 87,274 shares of common stock and 282,496 additional shares that will be acquired when currently unvested restricted stock units vest and settle.

Was the SGHT insider sale related to options or restricted stock units?

The sale was tied to restricted stock units, not options. Footnotes state the transaction covered the reporting person’s tax liability resulting from the vesting of RSUs, which are share-based awards that convert into common stock upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/09/2026 - 05:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HAYDEN JEREMY B.

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/06/2026		S		13,761(1)	D	$3.55(2)	369,770(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 87,274 shares of Common Stock, and (ii) 282,496 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)